Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen: results of a double-blind randomised phase III trial

✍ Scribed by M Kaufmann; E Bajetta; L.Y Dirix; L.E Fein; S.E Jones; J Cervek; C Fowst; A Polli; E Di Salle; G Massimini; G Piscitelli

• Book ID: 117656965
• Publisher: Elsevier Science
• Year: 2000
• Tongue: English
• Weight: 68 KB
• Volume: 36
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(00)00240-9